Stock Groups

Buy These 2 Diagnostic & Research Stocks After Reporting Better Than Expected Earnings Results -Breaking

by Mike Robinson

[ad_1]

© Reuters. Buy These 2 Diagnostic & Research Stocks After Reporting Better Than Expected Earnings Results

While the COVID-19 pandemic highlighted the importance of diagnostics and research services, the industry’s growth is expected to be sustained with increasing government funding and the prevalence of various chronic diseases that require therapies. It could make sense to invest in quality diagnostics stocks Quest Diagnostics DGX (NYSE:) as well as Quest Diagnostics DGX (DGX). They outperformed consensus earnings estimates during their latest quarter and showed strong financials. So, let’s discuss.The COVID-19 pandemic has accelerated the growth of the diagnostics and research industry over the past year. And, over the past months, the resurgence COVID-19 has provided additional growth opportunities to several companies. The prevalence of various chronic diseases and a rising demand for health care from an aging population should also drive the industry’s growth.

Additionally, the increasing investments by the government in healthcare and the incorporation of new technologies are positive for the research and diagnostic industry. A 6.1% compound annual growth rate is predicted for the global clinical diagnostics market, which will be $93.85 billion in 2026.

This backdrop suggests that we believe the shares of research and diagnostic companies Danaher Corporation DHR (NYSE:) and Quest Diagnostics Incorporated NASDAQ (NYSE) are solid investments. Analyst estimates have been high for these companies’ third-quarter earnings.

Continue reading on StockNews

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]